[
    "{\"step_by_step_thinking\": \"The patient is a 72-year-old woman who has smoked 20 cigarettes daily for the past 38 years. This smoking history puts her at risk for developing chronic obstructive pulmonary disease (COPD), which can cause shortness of breath. However, the shortness of breath occurred three days after starting eyedrops for glaucoma. Therefore, we need to consider the potential side effects of the eyedrops. Option A, Apraclonidine, is an alpha-2 adrenergic agonist that can cause systemic side effects such as dry mouth and drowsiness, but it is not known to cause shortness of breath. Option B, Epinephrine, is a non-selective adrenergic agonist that can cause bronchodilation and increased heart rate. While it can cause shortness of breath in some individuals, it is not commonly used as an eyedrop for glaucoma. Option C, Latanoprost, is a prostaglandin analog that can cause ocular side effects such as eye redness and eyelash growth, but it is not known to cause shortness of breath. Option D, Timolol, is a non-selective beta-adrenergic antagonist that is commonly used as an eyedrop for glaucoma. It can cause systemic side effects such as bradycardia and bronchospasm. Given the patient's smoking history and the timing of the shortness of breath, Timolol is the most likely cause of her symptoms.\", \"answer_choice\": \"D\"}"
]